Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2023 Earnings Call Transcript February 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $10.19 EPS, expectations were $10.43. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles